| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,732 | 10,707 | 34,287 | 28,459 | | Cost of Revenue | 4,099 | 5,692 | 24,954 | 20,363 | | | Gross Profit | 4,632 | 5,015 | 9,332 | 8,096 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,579 | 3,190 | 3,487 | 3,315 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 221 | 1,160 | 1,141 | 1,139 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 833 | 665 | 4,705 | 3,642 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (138) | 13 | 22 | 34 | | Earnings Before Interest And Taxes | 694 | 677 | 4,727 | 3,676 | | Interest Expense | 463 | 460 | 463 | 531 | | Income Before Tax | 231 | 217 | 4,264 | 3,145 | | Income Tax Expense | 92 | 79 | 1,620 | 1,196 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 139 | 137 | 2,644 | 1,949 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 139 | 137 | 2,644 | 1,949 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $139 | $137 | $2,644 | $1,949 |
|
0.41% Nasdaq 
Income Statement
